Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | KDR | P35968 | 8/20 | 0.36 |
| ▸ | MET | P08581 | 7/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | EP300 | Q09472 | 1/20 | 0.35 |
| ▸ | MEF2D | Q14814 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | FLT1 | P17948 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21167792 | 0.90 | SYK (0.35) | HDAC3KDRMETHDAC4EP300 | |
| SCHEMBL22475886 | 0.88 | HDAC3 (0.37) | HDAC3KDRHDAC4EP300MEF2D | |
| SCHEMBL21167434 | 0.86 | HDAC3 (0.38) | HDAC3KDRMETHDAC4EP300 | |
| SCHEMBL22475692 | 0.84 | HDAC3 (0.36) | HDAC3MET | |
| SCHEMBL22475862 | 0.83 | HDAC3 (0.36) | HDAC3KDRHDAC4EP300MEF2D | |
| SCHEMBL21167485 | 0.83 | HDAC3 (0.36) | HDAC3KDRHDAC4EP300MEF2D | |
| SCHEMBL22475900 | 0.82 | HDAC3 (0.36) | HDAC3KDRHDAC4EP300MEF2D | |
| SCHEMBL22475855 | 0.81 | HDAC3 (0.37) | HDAC3KDRHDAC4EP300MEF2D | |
| SCHEMBL22475722 | 0.81 | HDAC3 (0.41) | HDAC3KDRHDAC4EP300MEF2D | |
| SCHEMBL23128026 | 0.80 | HDAC3 (0.40) | HDAC3KDRHDAC4EP300MEF2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3795573-B1 | CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR | HUTCHISON MEDIPHARMA LTD (CN) | 2022-07-06 | — | — | EP | disclosed |
| EP-3511330-B1 | SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS | HUTCHISON MEDIPHARMA LTD (CN) | 2020-09-30 | — | — | EP | disclosed |